Veteran investor with experience across buyouts, growth equity and operational turnarounds, focusing on technology and healthcare sectors. Richard Harris brings senior leadership in deal sourcing, portfolio company governance and capital markets engagement, often leading value-creation programs and follow-on financings. Active on corporate boards, known for driving strategic repositioning and exit preparation. Relevant to LPs and advisors evaluating mid-market private equity allocations and management teams.
Veteran investor with experience across buyouts, growth equity and operational turnarounds, focusing on technology and healthcare sectors. Richard Harris brings senior leadership in deal sourcing, portfolio company governance and capital markets engagement, often leading value-creation programs and follow-on financings. Active on corporate boards, known for driving strategic repositioning and exit preparation. Relevant to LPs and advisors evaluating mid-market private equity allocations and management teams.
Combines buyout rigor with growth-equity flexibility, prioritizing control or influential minority positions in mid-market technology and healthcare companies where operational improvements unlock value. Emphasizes thesis-driven deal sourcing, hands-on governance, and staged capital deployment tied to measurable KPIs. Favors repeatable value-creation playbooks—product strategy, commercial scale-up, and margin expansion—while maintaining disciplined exit timing through active board oversight and capital markets readiness to optimize IRR and downside protection.
Combines buyout rigor with growth-equity flexibility, prioritizing control or influential minority positions in mid-market technology and healthcare companies where operational improvements unlock value. Emphasizes thesis-driven deal sourcing, hands-on governance, and staged capital deployment tied to measurable KPIs. Favors repeatable value-creation playbooks—product strategy, commercial scale-up, and margin expansion—while maintaining disciplined exit timing through active board oversight and capital markets readiness to optimize IRR and downside protection.
| Trades 652 | Longs Won 479/652 73% | Profit Factor 11.95 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $230,877.29 |
| Average Win $78,827.62 | Best Trade (Jul 17) $3.03M | Sharpe Ratio -14.85 |
| Average Loss -$18,264.59 | Worst Trade (Mar 30) -$532,539.18 | Z-Score 16.22 (100%) |
| Commissions $0 | Avg. Trade Length 10m 1w 4d | Expectancy $53,065.42 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 9,009 | 8,108 | 7,207 | 6,306 | 5,405 | 4,505 | 3,604 | 2,703 | 1,802 | 901 |